“Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy”. 2022. Farmeconomia. Health Economics and Therapeutic Pathways 23 (1). https://doi.org/10.7175/fe.v23i1.1516.